These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 7609999)
1. [Central mechanisms of neurogenic gastric lesion and its pharmacologic correction]. Bul'on VV Patol Fiziol Eksp Ter; 1995; (1):21-3. PubMed ID: 7609999 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacological analysis of the participation of serotonin in the central mechanisms of the development of a neurogenic stomach lesion in the rat]. Bul'on VV Farmakol Toksikol; 1988; 51(1):34-7. PubMed ID: 3258827 [TBL] [Abstract][Full Text] [Related]
3. [Mediator content of the rat brain in neurogenic gastric pathology]. Zavodskaia IS; Bul'on VV; Moreva EV Biull Eksp Biol Med; 1984 Feb; 97(2):135-6. PubMed ID: 6141824 [TBL] [Abstract][Full Text] [Related]
4. [Effect of L-DOPA on repair of neurogenic dystrophic damage to the gastric mucosa of rats]. Zabrodin ON; Bertash VI Biull Eksp Biol Med; 1976; 82(11):1347-9. PubMed ID: 1087890 [TBL] [Abstract][Full Text] [Related]
5. [The effect of GABA-ergic agents on the development of a neurogenic stomach lesion in rats]. Bul'on VV; Zavodskaia IS; Khnychenko LK Biull Eksp Biol Med; 1990 Nov; 110(11):504-6. PubMed ID: 1964607 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic analysis of the participation of endogenous noradrenaline in the retrograde development of neurogenic gastric dystrophy]. Zabrodin ON Farmakol Toksikol; 1972; 35(5):606-10. PubMed ID: 4652014 [No Abstract] [Full Text] [Related]
7. [The effect of neurotropic agents on lipid peroxidation in the heart and stomach with neurogenic lesions]. Bul'on VV; Zavodskaia IS; Khnychenko LK Eksp Klin Farmakol; 1994; 57(3):18-20. PubMed ID: 8049619 [TBL] [Abstract][Full Text] [Related]
8. [A pharmacological analysis of the central monoaminergic mechanisms of the development of neurogenic stomach damage]. Bul'on VV; Khnychenko LK Farmakol Toksikol; 1990; 53(2):36-8. PubMed ID: 1973391 [TBL] [Abstract][Full Text] [Related]
9. [Effect of phepracet and its derivatives on the development of neurogenic dystrophy of the stomach wall and the concentration of noradrenaline in it]. Zabrodin ON; Lapkin VA Farmakol Toksikol; 1977; 40(1):56-9. PubMed ID: 852547 [TBL] [Abstract][Full Text] [Related]
10. [Effects of lithium salts on experimental neurogenic lesions of the stomach and heart]. Kryzhanovskiĭ GN; Zavodskaia IS; Moreva EV Biull Eksp Biol Med; 1984 Jun; 97(6):653-5. PubMed ID: 6331544 [TBL] [Abstract][Full Text] [Related]
11. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Konturek PC; Brzozowski T; Walter B; Burnat G; Hess T; Hahn EG; Konturek SJ Eur J Pharmacol; 2006 Apr; 536(1-2):171-81. PubMed ID: 16581065 [TBL] [Abstract][Full Text] [Related]
12. [The effect of central neurotropic drugs on the development of reflex gastric dystrophy]. Moreva EV; Zabrodin ON; Shalupnia AS; Repetun IN Farmakol Toksikol; 1972; 35(5):603-5. PubMed ID: 4652013 [No Abstract] [Full Text] [Related]
13. Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. Kwiecień S; Brzozowski T; Konturek PC; Pawlik MW; Pawlik WW; Kwiecień N; Konturek SJ J Physiol Pharmacol; 2004 Jun; 55(2):337-55. PubMed ID: 15213357 [TBL] [Abstract][Full Text] [Related]
14. Effects of afferent and efferent celiac nerves on acute gastric lesions: due to changes in blood flow? Anan K; Donahue PE; Doyle MD; Nyhus LM Am Surg; 1993 Aug; 59(8):500-4. PubMed ID: 8338279 [TBL] [Abstract][Full Text] [Related]
15. [Effect of alpha-methyl-p-tyrosine on the development of neurogenic dystrophy in the gastric wall and on its noradrenaline content]. Zabrodin ON Biull Eksp Biol Med; 1975 Jun; 79(6):30-2. PubMed ID: 1222245 [TBL] [Abstract][Full Text] [Related]
16. [The effect of l-DOPA on the development of neurogenic dystrophies]. Zavodskaia IS; Moreva EV; Isachenko VB; Novikova NA; Zaskal'ko NI Farmakol Toksikol; 1972; 35(5):595-600. PubMed ID: 4652012 [No Abstract] [Full Text] [Related]
17. [The effect of hexonium on the biochemical and morphologic changes in the wall of a stomach affected by neurogenic dystrophy]. Zavodskaia IS; Moreva EV Farmakol Toksikol; 1972; 35(5):600-2. PubMed ID: 4405634 [No Abstract] [Full Text] [Related]
18. [Change in the concentration of nucleic acids and cAMP in neurogenic dystrophies of the stomach]. Zavodskaia IS; Migas EA Biull Eksp Biol Med; 1978 Apr; 85(4):405-7. PubMed ID: 207370 [TBL] [Abstract][Full Text] [Related]
19. [Effect of DOPA and alpha-methyl-DOPA on the development of neurogenic dystrophy of the gastric wall and catecholamine content of the stomach]. Zabrodin ON Biull Eksp Biol Med; 1970 Jul; 70(7):58-60. PubMed ID: 5501776 [No Abstract] [Full Text] [Related]
20. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions. de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]